Literature DB >> 23835946

Protective effect of bilobalide on learning and memory impairment in rats with vascular dementia.

Wei-Zu Li1, Wang-Yang Wu, Huan Huang, Yang-Yang Wu, Yan-Yan Yin.   

Abstract

Vascular dementia (VD) is the second most common type of dementia in the elderly. Currently, there are no effective drugs for preventing or decreasing the progression of dementia. Bilobalide (BB) is a monomer extracted from Ginkgo biloba leaves. The present study investigated the neuroprotective effects of BB in a two-vessel occlusion (2-VO)-induced VD rat model. The results showed that BB (4 and 8 mg/kg) significantly protected VD rats against cognitive deficits in the Morris water maze. Biochemical assessment showed that BB (4 and 8 mg/kg) increased superoxide dismutase (SOD) activity and glutathione (GSH) content, and decreased nitric oxide synthase (NOS) activity and malondialdehyde (MDA) content. Additionally, BB (4 and 8 mg/kg) was found to alleviate neuronal apoptosis and to reduce the expression of tumor necrosis factor-α (TNF-α) in the brain cortex and the hippocampal CA1 region in VD rats. These results suggest that BB provides protection against learning and memory impairment by reducing free radical injury and inhibiting neuronal apoptosis in the brain cortex and hippocampal CA1 region in VD rats.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23835946     DOI: 10.3892/mmr.2013.1573

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  11 in total

1.  Antioxidant effects of ginkgolides and bilobalide against cerebral ischemia injury by activating the Akt/Nrf2 pathway in vitro and in vivo.

Authors:  Qiu Liu; Zhiquan Jin; Zhiliang Xu; Hao Yang; Liang Li; Guiping Li; Fang Li; Shaoli Gu; Shaobo Zong; Jun Zhou; Liang Cao; Zhenzhong Wang; Wei Xiao
Journal:  Cell Stress Chaperones       Date:  2019-02-27       Impact factor: 3.667

Review 2.  Post-stroke cognitive impairment: epidemiology, mechanisms and management.

Authors:  Jia-Hao Sun; Lan Tan; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2014-08

Review 3.  Models and mechanisms of vascular dementia.

Authors:  Poornima Venkat; Michael Chopp; Jieli Chen
Journal:  Exp Neurol       Date:  2015-05-15       Impact factor: 5.330

4.  Chronic cerebral hypoperfusion and plasticity of the posterior cerebral artery following permanent bilateral common carotid artery occlusion.

Authors:  Kyung-Ok Cho; Seul-Ki Kim; Seong Yun Kim
Journal:  Korean J Physiol Pharmacol       Date:  2017-10-30       Impact factor: 2.016

Review 5.  Herbal Medicine for the Treatment of Vascular Dementia: An Overview of Scientific Evidence.

Authors:  Dennis Chang; Jianxun Liu; Kellie Bilinski; Li Xu; Genevieve Z Steiner; Sai W Seto; Alan Bensoussan
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-27       Impact factor: 2.629

6.  Effect of Yin-Xing-Tong-Zhi Tablets on Improving Vascular Cognitive Impairment No Dementia.

Authors:  Weidong Pan; Wei Zhu; Qi Gao; Weilong Liao; Penglin Gao; Te Liu
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-26       Impact factor: 2.629

7.  Enhancing amplification of late-outgrowth endothelial cells by bilobalide.

Authors:  Shuqin Liu; Xiaoye Hou; Lina Chen; Hao Hu; Qiang Sun; Feng Zhao; Chuanhao Liu
Journal:  J Cell Mol Med       Date:  2018-03-22       Impact factor: 5.310

8.  Effects of CREB1 gene silencing on cognitive dysfunction by mediating PKA-CREB signaling pathway in mice with vascular dementia.

Authors:  Xin-Rui Han; Xin Wen; Yong-Jian Wang; Shan Wang; Min Shen; Zi-Feng Zhang; Shao-Hua Fan; Qun Shan; Liang Wang; Meng-Qiu Li; Bin Hu; Chun-Hui Sun; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  Mol Med       Date:  2018-05-03       Impact factor: 6.354

9.  Establishment of an animal model of vascular dementia.

Authors:  Hao Wang
Journal:  Exp Ther Med       Date:  2014-08-21       Impact factor: 2.447

Review 10.  Small Vessel Disease-Related Dementia: An Invalid Neurovascular Coupling?

Authors:  Rita Moretti; Paola Caruso
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.